Dysplastic nevi are moles that look unusual under the naked eye and show abnormal cell patterns under a microscope. They’re not cancer, but they signal a higher-than-average risk of developing melanoma. Somewhere between 2% and 18% of the general population has at least one, with estimates closer to 10% among people of northern European descent.
How Dysplastic Nevi Differ From Common Moles
A common mole is typically round, evenly colored, and smaller than a pencil eraser. Dysplastic nevi break those rules in several ways. They tend to have a mixture of colors ranging from pink to dark brown within the same mole. Their borders are irregular and often fade gradually into the surrounding skin rather than stopping at a clean edge. The surface is usually flat with a slightly scaly or pebbly texture, though some develop a raised center surrounded by a flat rim, sometimes described as a “fried egg” appearance.
Many dysplastic nevi are also larger than 6 mm (about the diameter of a pencil eraser), though size alone doesn’t make a mole atypical. What matters is the combination of uneven color, irregular shape, and blurred borders. Dermatologists use the ABCDE framework to evaluate suspicious moles: asymmetric shape, border irregularity, color variegation, diameter greater than 6 mm, and evolution or change over time. Dysplastic nevi often check several of these boxes, which is exactly why they get flagged for closer inspection.
What Happens Under the Microscope
Looking unusual on the surface isn’t enough for a formal diagnosis. The term “dysplastic nevus” is ultimately a pathology diagnosis, meaning a dermatopathologist examines the tissue under a microscope and grades the degree of abnormality based on two features: how disorganized the mole’s architecture is (the overall structure and arrangement of cells) and how atypical the individual pigment-producing cells look.
The most recent World Health Organization classification system recognizes two grades: low-grade dysplasia and high-grade dysplasia. Moles that used to be labeled “mildly atypical” are no longer classified as dysplastic at all. The reasoning is straightforward: those very mildly irregular moles are extremely common, their microscopic features are hard for pathologists to agree on consistently, and they carry a very low risk of progressing to melanoma. Reclassifying them avoids unnecessary anxiety and follow-up procedures for patients whose moles pose minimal concern.
High-grade dysplasia involves larger, more irregularly shaped pigment cells with abnormal nuclei and a more disorganized growth pattern. These moles get the most clinical attention because they sit closer on the spectrum to early melanoma, even though the vast majority never become cancerous.
The Connection to Melanoma
Dysplastic nevi are best understood as a marker of risk rather than a direct precursor to skin cancer. While a small number of melanomas do arise within a pre-existing dysplastic nevus, the overall rate of any single atypical mole transforming into melanoma is low. The bigger signal is what having these moles says about your skin biology. If your body produces atypical moles, you may be more susceptible to the cellular changes that lead to melanoma elsewhere on your skin, not just within the atypical mole itself.
The risk scales with the number of atypical moles you have. A person with one or two dysplastic nevi has a modestly elevated risk. Someone with many atypical moles, especially combined with a large total mole count (more than 50), occupies a higher risk category and benefits from more frequent skin checks.
Familial Atypical Multiple Mole Melanoma Syndrome
Some people inherit a genetic predisposition that produces large numbers of dysplastic nevi alongside a strong family history of melanoma. This condition, called FAMMM syndrome, follows an autosomal dominant inheritance pattern, meaning a single copy of the affected gene from one parent is enough to confer risk. The hallmark features are 50 or more moles (many of them atypical) plus one or more close relatives who have had melanoma.
FAMMM is linked to mutations in a gene called CDKN2A, which normally produces proteins that help control cell growth. When these proteins don’t function properly, cells are less able to put the brakes on abnormal division. Families with CDKN2A mutations also face elevated rates of pancreatic cancer, making a thorough family cancer history an important part of evaluation. The syndrome shows variable expressivity, which means even within the same family, some carriers develop many atypical moles and melanoma while others may show milder features.
The Role of Sun Sensitivity
The relationship between sun exposure and dysplastic nevi is more nuanced than you might expect. Research has found that total sun exposure hours don’t clearly predict whether someone will develop atypical moles. What does matter is sun sensitivity, specifically how your skin responds to UV light. People who tan lightly or not at all after repeated sun exposure are at higher risk of developing dysplastic nevi than people who tan deeply. This suggests that an inherited skin type prone to sun damage plays a larger role than the amount of time spent outdoors.
That said, UV radiation is the primary environmental driver of melanoma. Since dysplastic nevi mark a person as melanoma-prone, protecting your skin from excessive UV exposure remains important regardless of how many atypical moles you have.
How Dysplastic Nevi Are Diagnosed
Diagnosis typically starts with a visual exam, often aided by dermoscopy, a handheld device that illuminates and magnifies the skin’s surface structures. If a mole looks concerning, your dermatologist will perform a biopsy, removing all or part of the mole so a pathologist can examine the cells.
The most common initial approach is a shave biopsy, which removes the visible portion of the mole with a thin blade. Research shows that in 76% to 79% of cases, all abnormal cells are removed during this initial shave. When the edges of the biopsy sample still contain atypical cells (called positive margins), the question becomes whether to remove more tissue or simply monitor the site. Full-thickness surgical excision clears remaining atypical cells about 87.5% of the time, compared to roughly 76% for a second shave. Your dermatologist will weigh the grade of atypia, the location on your body, and your overall risk profile when recommending next steps.
Monitoring and Long-Term Management
Not every dysplastic nevus needs to be cut out. For low-grade lesions with clear biopsy margins, observation is a reasonable and common approach. Your dermatologist may photograph your moles to create a baseline map, making it easier to spot changes at future visits. Some practices use total-body photography or digital dermoscopy to track individual moles over time, which is especially useful for people with many atypical moles.
How often you need skin checks depends on your overall risk. Someone with a handful of low-grade dysplastic nevi and no family history of melanoma might be seen once a year. A person with FAMMM syndrome or a personal history of melanoma may need exams every three to six months. Between appointments, monthly self-exams help catch changes early. Look for moles that are growing, changing color, developing new irregular borders, or behaving differently from the moles around them.
For high-grade dysplastic nevi, or any mole where the biopsy shows features that are difficult to distinguish from very early melanoma, complete surgical removal with clear margins is the standard recommendation. The procedure is straightforward, typically done in the office under local anesthesia, and recovery involves basic wound care for one to two weeks.